122 related articles for article (PubMed ID: 9787294)
1. [Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
Sinzinger H
Dtsch Med Wochenschr; 1998 Sep; 123(38):1116-22. PubMed ID: 9787294
[No Abstract] [Full Text] [Related]
2. [Statins have other beneficial properties besides their cholesterol lowering effect].
Eriksson M
Lakartidningen; 1998 Aug; 95(35):3670-2. PubMed ID: 9748780
[TBL] [Abstract][Full Text] [Related]
3. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia.
Branchi A; Rovellini A; Sommariva D; Gugliandolo AG; Fasoli A
Thromb Haemost; 1993 Aug; 70(2):241-3. PubMed ID: 8236126
[TBL] [Abstract][Full Text] [Related]
4. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
Branchi A; Rovellini A; Fiorenza AM; Sommariva D
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):345-50. PubMed ID: 7582386
[TBL] [Abstract][Full Text] [Related]
5. Heart lines. Do statins make blood less sticky?
Harv Heart Lett; 1999 Sep; 10(1):6-7. PubMed ID: 10445972
[No Abstract] [Full Text] [Related]
6. Short-term effects of fluvastatin, a hydroxylmethylglutaryl-coenzyme A reductase inhibitor, on coagulation and the fibrinolytic system in patients with hypercholesterolemia.
Saito M; Asakura H; Morishita E; Yamazaki M; Matsuda T
Int J Hematol; 1999 Jun; 69(4):274-6. PubMed ID: 10407589
[No Abstract] [Full Text] [Related]
7. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
De Vries AC; Vermeer MA; Bredman JJ; Bär PR; Cohen LH
Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet actions of statins and fibrates are mediated by PPARs.
Ali FY; Armstrong PC; Dhanji AR; Tucker AT; Paul-Clark MJ; Mitchell JA; Warner TD
Arterioscler Thromb Vasc Biol; 2009 May; 29(5):706-11. PubMed ID: 19150877
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
McKenney JM
Am J Cardiol; 2005 Aug; 96(4A):60E-66E. PubMed ID: 16098846
[TBL] [Abstract][Full Text] [Related]
10. Statins do more than just lower cholesterol.
Vaughan CJ; Murphy MB; Buckley BM
Lancet; 1996 Oct; 348(9034):1079-82. PubMed ID: 8874463
[No Abstract] [Full Text] [Related]
11. Fibrates and HMG-CoA reductase inhibitors.
Huff MW
CMAJ; 1991 Oct; 145(8):977. PubMed ID: 1913432
[No Abstract] [Full Text] [Related]
12. [Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant].
Stalenhoef AF; Stehouwer CD
Ned Tijdschr Geneeskd; 2000 Feb; 144(7):308-10. PubMed ID: 10707739
[TBL] [Abstract][Full Text] [Related]
13. Role of fibrates in reducing coronary risk: a UK Consensus.
UK HDL-C Consensus Group
Curr Med Res Opin; 2004; 20(2):241-7. PubMed ID: 15006019
[TBL] [Abstract][Full Text] [Related]
14. Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.
Rasi VP; Torstila I
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):109-11. PubMed ID: 1019149
[No Abstract] [Full Text] [Related]
15. The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.
Dierkes J; Westphal S; Luley C
Expert Opin Drug Saf; 2004 Mar; 3(2):101-11. PubMed ID: 15006716
[TBL] [Abstract][Full Text] [Related]
16. The effects of fibrates on lipoprotein and hemostatic coronary risk factors.
Schonfeld G
Atherosclerosis; 1994 Dec; 111(2):161-74. PubMed ID: 7718018
[TBL] [Abstract][Full Text] [Related]
17. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
Martínez-Castelao A
Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
[No Abstract] [Full Text] [Related]
18. Effects of hypolipemic drugs on the osteoprotegerin - sRANKL system in patients with coronary artery disease.
Celińska-Löwenhoff M; Löwenhoff T; Undas A; Gluszko P
Thromb Haemost; 2007 May; 97(5):868-70. PubMed ID: 17479201
[No Abstract] [Full Text] [Related]
19. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
20. Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions.
Davidson MH
Expert Opin Drug Saf; 2006 Jan; 5(1):145-56. PubMed ID: 16370963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
